Ziegler H
Medizinische Abteilung, Kreuzspital, Chur.
Schweiz Med Wochenschr. 1988 Nov 19;118(46):1698-701.
As part of the international multicentre ISIS-2 study, 20 patients with acute myocardial infarction have been randomized for treatment with streptokinase in this district hospital since summer 1986. Twelve received active streptokinase. The treatment has proved practicable and free of serious problems, even in a smaller-size hospital, provided the patients are carefully selected.
作为国际多中心 ISIS - 2 研究的一部分，自 1986 年夏季以来，该地区医院已有 20 例急性心肌梗死患者被随机分配接受链激酶治疗。其中 12 例接受了活性链激酶治疗。事实证明，只要对患者进行仔细挑选，即使在规模较小的医院，这种治疗也是可行的，且不存在严重问题。
